Brimonidine Tartrate (Osmotica Pharmaceutical Corp.)
Welcome to the PulseAid listing for the Brimonidine Tartrate drug offered from Osmotica Pharmaceutical Corp.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Osmotica Pharmaceutical Corp. |
NON-PROPRIETARY NAME: | Brimonidine Tartrate |
SUBSTANCE NAME: | BRIMONIDINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
Brimonidine Tartrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Brimonidine Tartrate from Osmotica Pharmaceutical Corp. |
LABELER NAME: | Osmotica Pharmaceutical Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mg) |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42843-501_ff8c0119-caff-432c-a447-625547599e7e |
PRODUCT NDC: | 42843-501 |
APPLICATION NUMBER: | ANDA091691 |
Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers: